- Report
- August 2023
- 151 Pages
Middle East, Africa
From €1332EUR$1,500USD£1,161GBP
- Report
- August 2023
- 149 Pages
Europe
From €1332EUR$1,500USD£1,161GBP
- Report
- October 2025
- 85 Pages
Kuwait
From €4308EUR$4,850USD£3,753GBP
From €4308EUR$4,850USD£3,753GBP
- Report
- October 2025
- 99 Pages
Kuwait
From €4308EUR$4,850USD£3,753GBP
- Report
- May 2025
- 130 Pages
Global
From €4308EUR$4,850USD£3,753GBP
- Report
- May 2025
- 210 Pages
Global
From €3997EUR$4,500USD£3,482GBP
- Report
- April 2025
- 120 Pages
Global
From €4308EUR$4,850USD£3,753GBP
- Report
- April 2025
- 140 Pages
Global
From €4308EUR$4,850USD£3,753GBP
- Report
- March 2025
- 76 Pages
Global
From €3104EUR$3,495USD£2,705GBP
- Report
- March 2025
- 75 Pages
Global
From €3104EUR$3,495USD£2,705GBP
- Report
- March 2025
- 220 Pages
Global
From €4308EUR$4,850USD£3,753GBP
- Report
- March 2025
- 54 Pages
China
From €1599EUR$1,800USD£1,393GBP
- Report
- March 2025
- 230 Pages
China
From €3553EUR$4,000USD£3,095GBP
- Report
- March 2025
- 86 Pages
China
From €1599EUR$1,800USD£1,393GBP
- Report
- December 2024
- 436 Pages
Global
From €3553EUR$4,000USD£3,095GBP
- Report
- November 2024
- 345 Pages
Global
From €3553EUR$4,000USD£3,095GBP
- Report
- November 2024
- 454 Pages
Global
From €3553EUR$4,000USD£3,095GBP
- Report
- November 2024
- 56 Pages
Global
From €2221EUR$2,500USD£1,935GBP
- Report
- October 2024
- 266 Pages
Global
From €3553EUR$4,000USD£3,095GBP

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events.
The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more